These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 26988924)

  • 1. Statin intake is associated with MMP-1 level in gingival crevicular fluid of patients with periodontitis.
    Poston CJ; Pierce TC; Li Y; Brinson CW; Lu Z; Lauer AW; Leite RS; Huang Y
    Oral Dis; 2016 Jul; 22(5):438-44. PubMed ID: 26988924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gingival crevicular fluid matrix metalloproteinase (MMP)-7, extracellular MMP inducer, and tissue inhibitor of MMP-1 levels in periodontal disease.
    Emingil G; Tervahartiala T; Mãntylã P; Määttä M; Sorsa T; Atilla G
    J Periodontol; 2006 Dec; 77(12):2040-50. PubMed ID: 17209789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of oral fluid MMP-8 with periodontitis in Swiss adult subjects.
    Mauramo M; Ramseier AM; Mauramo E; Buser A; Tervahartiala T; Sorsa T; Waltimo T
    Oral Dis; 2018 Apr; 24(3):449-455. PubMed ID: 28889479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A matrix metalloproteinase inhibitor reduces bone-type collagen degradation fragments and specific collagenases in gingival crevicular fluid during adult periodontitis.
    Golub LM; Lee HM; Greenwald RA; Ryan ME; Sorsa T; Salo T; Giannobile WV
    Inflamm Res; 1997 Aug; 46(8):310-9. PubMed ID: 9297576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of adjunctive low-dose doxycycline therapy on clinical parameters and gingival crevicular fluid matrix metalloproteinase-8 levels in chronic periodontitis.
    Emingil G; Atilla G; Sorsa T; Luoto H; Kirilmaz L; Baylas H
    J Periodontol; 2004 Jan; 75(1):106-15. PubMed ID: 15025222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative evaluation of semaphorin-4D, peptidylarginine deiminase-2, and matrix metalloproteinase-8 levels of gingival crevicular fluid in periodontally healthy and Stage III periodontitis smoker and non-smoker patients before and after non-surgical periodontal therapy.
    Ikhar AS; Kolte RA; Kolte AP; Rathi PR; Ghoderao DG; Dahake RN
    J Periodontol; 2024 Jun; 95(6):563-570. PubMed ID: 37846733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of phase I periodontal treatment on gingival crevicular fluid levels of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1.
    Tüter G; Kurtiş B; Serdar M
    J Periodontol; 2002 May; 73(5):487-93. PubMed ID: 12027249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinase (MMP)-8 and tissue inhibitor of MMP-1 (TIMP-1) gene polymorphisms in generalized aggressive periodontitis: gingival crevicular fluid MMP-8 and TIMP-1 levels and outcome of periodontal therapy.
    Emingil G; Han B; Gürkan A; Berdeli A; Tervahartiala T; Salo T; Pussinen PJ; Köse T; Atilla G; Sorsa T
    J Periodontol; 2014 Aug; 85(8):1070-80. PubMed ID: 24283658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The short-term effectiveness of non-surgical treatment in reducing levels of interleukin-1beta and proteases in gingival crevicular fluid from patients with type 2 diabetes mellitus and chronic periodontitis.
    Correa FO; Gonçalves D; Figueredo CM; Gustafsson A; Orrico SR
    J Periodontol; 2008 Nov; 79(11):2143-50. PubMed ID: 18980523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gingival crevicular fluid levels of matrix metalloproteinases cross-sectionally related to periodontitis and metabolic syndrome in community Koreans.
    Han DH; Shin HS; Paek D; Kim HD
    J Clin Periodontol; 2012 Dec; 39(12):1125-31. PubMed ID: 23036163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinases and their inhibitors in gingival crevicular fluid and saliva of periodontitis patients.
    Ingman T; Tervahartiala T; Ding Y; Tschesche H; Haerian A; Kinane DF; Konttinen YT; Sorsa T
    J Clin Periodontol; 1996 Dec; 23(12):1127-32. PubMed ID: 8997658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gingival crevicular fluid matrix metalloproteinase-8 levels following adjunctive use of meloxicam and initial phase of periodontal therapy.
    Buduneli N; Vardar S; Atilla G; Sorsa T; Luoto H; Baylas H
    J Periodontol; 2002 Jan; 73(1):103-9. PubMed ID: 11846190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The utility of gingival crevicular fluid matrix metalloproteinase-8 response patterns in prediction of site-level clinical treatment outcome.
    Leppilahti JM; Sorsa T; Kallio MA; Tervahartiala T; Emingil G; Han B; Mäntylä P
    J Periodontol; 2015 Jun; 86(6):777-87. PubMed ID: 25741578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GCF MMP-8 levels in smokers and non-smokers with chronic periodontitis following scaling and root planing accompanied by systemic use of flurbiprofen.
    Kurtis B; Tüter G; Serdar M; Pinar S; Demirel I; Toyman U
    J Periodontol; 2007 Oct; 78(10):1954-61. PubMed ID: 18062117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of MMP-8 in Salivary and Gingival Crevicular Fluids of Periodontitis Patients.
    Fatemi K; Rezaee SA; Banihashem SA; Keyvanfar S; Eslami M
    Iran J Immunol; 2020 Sep; 17(3):236-243. PubMed ID: 32996900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of scaling and root planing and subantimicrobial dose doxycycline on gingival crevicular fluid levels of matrix metalloproteinase-8, -13 and serum levels of HsCRP in patients with chronic periodontitis.
    Tüter G; Serdar M; Kurtiş B; Walker SG; Atak A; Toyman U; Pinar S; Aykan T
    J Periodontol; 2010 Aug; 81(8):1132-9. PubMed ID: 20370419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gingival crevicular fluid matrix metalloproteinase-8 levels predict treatment outcome among smokers with chronic periodontitis.
    Leppilahti JM; Kallio MA; Tervahartiala T; Sorsa T; Mäntylä P
    J Periodontol; 2014 Feb; 85(2):250-60. PubMed ID: 23659421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PGE2, IL-1 beta, and TNF-alpha responses in diabetics as modifiers of periodontal disease expression.
    Salvi GE; Beck JD; Offenbacher S
    Ann Periodontol; 1998 Jul; 3(1):40-50. PubMed ID: 9722689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of gingival crevicular fluid levels of tissue plasminogen activator, plasminogen activator inhibitor 2, matrix metalloproteinase-3 and interleukin 1-β in patients with different periodontal diseases.
    Toyman U; Tüter G; Kurtiş B; Kıvrak E; Bozkurt Ş; Yücel AA; Serdar M
    J Periodontal Res; 2015 Feb; 50(1):44-51. PubMed ID: 24690077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The adjunctive effect of tenoxicam during non-surgical periodontal treatment on clinical parameters and gingival crevicular fluid levels of MMP-8 and TNF-α in patients with chronic periodontitis - randomized, double-blind clinical trial.
    Ozgören O; Develioglu H; Güncü G; Akman A; Berker E
    Adv Clin Exp Med; 2014; 23(4):559-65. PubMed ID: 25166440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.